| 4408 |
Centers for Disease Control and Prevention |
Video |
en |
This Is Personal | Terrence Howard | Talks on Colon Cancer |
Golden Globe® and Academy Award® nominated actor and musician Terrence Howard has joined CDC's Screen for Life: National Colorectal Cancer Action Campaign! Mr. Howard talks about his mother, her influence on him, and how her death from colon cancer affected his whole family. He says, "This is personal but there is something you can do to prevent this disease." He urges men and women aged 50 and older to be screened for colorectal cancer.
The public service announcements featuring Mr. Howard were created by CDC's Screen for Life: National Colorectal Cancer Action Campaign in partnership with the National Colorectal Cancer Research Alliance, a program of the Entertainment Industry Foundation.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://www.cdc.gov/cancer/colorectal/sfl/psa.htm |
|
|
CLICK HERE |
| 4875 |
Centers for Disease Control and Prevention |
Html |
en |
Winnable Battles - Resources |
CDC's Winnable Battles are public health priorities with large-scale impact on health and with known, effective strategies to address them. |
| Background information | 0.337783 |
| img src= | 0.326879 |
| Page | 0.242789 |
| in-depth overview | 0.314436 |
| Winnable Battle topic | 0.633114 |
| specific Winnable Battle | 0.647068 |
| action items | 0.326985 |
| general overview | 0.322047 |
| narrated presentations | 0.325804 |
| media coverage | 0.336344 |
| Questions | 0.223359 |
| state | 0.221132 |
| href= | 0.220133 |
| public health | 0.322043 |
| hear | 0.224557 |
|
| height | 0.226083 |
| order | 0.219754 |
| CDC’s Winnable | 0.698939 |
| area | 0.242536 |
| border | 0.220488 |
| goals. | 0.233789 |
| community levels | 0.318877 |
| strategies | 0.219962 |
| Winnable Battles | 0.904222 |
| Winnable Battles targets | 0.798388 |
| overview PowerPoint presentation | 0.443575 |
| http://www.cdc.gov/winnablebattles/?s_cid=bb-winnable-battles-001″ title= | 0.317575 |
| width | 0.226256 |
| progress | 0.242049 |
| Learn | 0.226513 |
|
CLICK HERE |
| 5367 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, May 30, 2011 |
null |
| Immunization Safety Assessment | 0.755782 |
| time series study | 0.719445 |
| workers exposure assessment | 0.728023 |
| multicentre implementation study | 0.744098 |
| Physical activity level | 0.730806 |
| immunization information | 0.681163 |
| heart disease prevalence | 0.742888 |
| Eur J Hum | 0.674864 |
| CDC Science Clips | 0.955748 |
| young children | 0.683296 |
| vaccine adverse events | 0.735402 |
| Rhyne RL | 0.674873 |
| National Heart | 0.684136 |
| Mandatory public reporting | 0.734753 |
| national population survey | 0.719034 |
| body mass index | 0.729018 |
| Chief Science Officer | 0.754754 |
| Khoury MJ | 0.674538 |
| Hindorff LA | 0.673269 |
| Xpert MTB/RIF test | 0.736115 |
| Blood Institute | 0.681711 |
| information sources | 0.687437 |
| Clin Chim Acta. | 0.729145 |
| hospitality industry legislation | 0.714457 |
| public domain | 0.686355 |
|
| Stephen B. Thacker | 0.876185 |
| Engler RJ | 0.675467 |
| hospital-acquired infection rates | 0.732233 |
| Vaccine attitudes | 0.677029 |
| blood pressure levels | 0.730062 |
| human variation | 0.673313 |
| sudden cardiac death | 0.740131 |
| Occup Environ Med. | 0.733581 |
| weekly digest | 0.675717 |
| childhood rotavirus immunization | 0.732414 |
| Cigarette package health | 0.724282 |
| U.S. adults | 0.72418 |
| public health literature | 0.736855 |
| B. Thacker CDC | 0.950767 |
| human genetic associations | 0.739928 |
| health care practitioners | 0.723775 |
| original sources | 0.692792 |
| West Nile virus | 0.722793 |
| Malar J. | 0.674954 |
| news sources | 0.673625 |
| HealthStyles survey | 0.677286 |
| genome-wide association studies | 0.738242 |
| Thacker CDC Library | 0.950723 |
| acute myocardial infarction | 0.717327 |
|
CLICK HERE |
| 9327 |
Centers for Disease Control and Prevention |
Html |
es |
Efectos en la actividad física por los cambios en el ambiente construido de un vecindario afroamericano de bajos recursos |
CDC - Wide Page example description goes here |
| Rice J | 0.592432 |
| African American neighborhood | 0.868312 |
| Farley TA | 0.630397 |
| comparación basándonos | 0.701646 |
| physical activity | 0.661003 |
| bajos niveles | 0.658069 |
|
| neighborhood built environment | 0.933174 |
| salud pública | 0.895663 |
| Gustat J | 0.573492 |
| Becker AB | 0.599719 |
| bajos recursos | 0.921311 |
| Chronic Dis | 0.617028 |
|
CLICK HERE |
| 10696 |
Centers for Disease Control and Prevention |
Html |
en |
Viral Hemorrhagic Fevers - VHF' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11242 |
Centers for Disease Control and Prevention |
Html |
es |
Evalúe sus conocimientosde la hemocromatosis |
Julio es el Mes de Concientización sobre la Hemocromatosis. ¿Qué tanto sabe de esta afección? Responda las preguntas para averiguarlo. |
|
|
CLICK HERE |
| 12299 |
Centers for Disease Control and Prevention |
Html |
en |
Non-Polio Enterovirus | Laboratory Testing and Procedures | Picornavirus | CDC |
Laboratory testing of non-polio enteroviruses and other picornaviruses |
| MPEG | 0.408807 |
| new diagnostic technologies | 0.96715 |
| CDC | 0.408358 |
| molecular testing | 0.734664 |
| training | 0.362732 |
| different file formats | 0.93071 |
| clinical specimens | 0.688139 |
|
| PDF | 0.359386 |
| PPT | 0.446893 |
| guidance | 0.389728 |
| techniques | 0.362001 |
| virus isolation | 0.77509 |
| DOC | 0.402935 |
|
CLICK HERE |
| 12903 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Increase in Reported Crimean-CongoHemorrhagic Fever Cases - Country of Georgia, 2014 |
Ashley L. Greiner, MD1,2, Nana Mamuchishvili3, Stephanie J. Salyer2, DVM, Kendra Stauffer4, DVM, Marika Geleishvili, MD4, Khatuna Zakhashvili, MD3, Juliette Morgan, MD4 (Author affiliations at end of text). |
| national surveillance | 0.672285 |
| Public health interventions | 0.672206 |
| ongoing CCHF surveillance | 0.789519 |
| infected animal blood | 0.674675 |
| surveillance system sensitivity | 0.725058 |
| Disease Control | 0.685851 |
| nonspecific febrile illness | 0.704428 |
| Stephanie J. Salyer | 0.693626 |
| Ashley L. Greiner | 0.85057 |
| passive CCHF surveillance | 0.818436 |
| surveillance sensitivity | 0.747265 |
| national reference laboratory | 0.672553 |
| risk factors | 0.669438 |
| surveillance data | 0.669151 |
| Global Health | 0.700113 |
| milder CCHF cases | 0.752646 |
| CCHF diagnostic testing | 0.720615 |
| improved surveillance | 0.655023 |
| nationwide educational campaign | 0.669051 |
| high-priority bioterrorism agent | 0.68265 |
| acute febrile illness | 0.795677 |
| crimean-congo hemorrhagic fever | 0.926754 |
| Georgia | 0.778404 |
| rural villages | 0.67816 |
| 1Epidemic Intelligence Service | 0.656126 |
|
| CCHF | 0.910443 |
| febrile illness studies | 0.800163 |
| Integrated Disease Surveillance | 0.754802 |
| annual case | 0.6783 |
| CCHF nucleic acid | 0.734041 |
| future public health | 0.678231 |
| infected tick | 0.727512 |
| Reported Crimean-Congo Hemorrhagic | 0.823555 |
| viral hemorrhagic fever | 0.758597 |
| health care workers | 0.668002 |
| CCHF testing | 0.657389 |
| public health | 0.833822 |
| Global Health Protection | 0.674583 |
| educational campaigns | 0.657513 |
| hemorrhagic sign | 0.66332 |
| 4South Caucasus Country | 0.663144 |
| CCHF physician awareness | 0.727059 |
| safe tick handling | 0.692009 |
| annual case count | 0.673681 |
| mean incubation period | 0.663185 |
| peak tick activity | 0.690265 |
| physician educational campaigns | 0.654306 |
| CCHF patients | 0.744978 |
| hemorrhagic signs | 0.726741 |
|
CLICK HERE |
| 13585 |
Centers for Disease Control and Prevention |
Html |
en |
Enterovirus and Human Parechovirus Surveillance - UnitedStates, 2009-2013 |
Glen R. Abedi, MPH1; John T. Watson, MD1; Huong Pham, MPH1; W. |
| commonly reported types | 0.57357 |
| HPeV molecular typing | 0.461647 |
| annual detections | 0.461129 |
| specific EV types | 0.578971 |
| public health practitioners | 0.595657 |
| National Enterovirus Surveillance | 0.500759 |
| mouth disease | 0.568089 |
| monthly NESS reporting | 0.523313 |
| Susan I. Gerber | 0.47114 |
| virus types | 0.485007 |
| detections | 0.554966 |
| private reference laboratory | 0.467289 |
| positive tests | 0.501825 |
| frequently reported specimen | 0.547246 |
| M. Steven Oberste | 0.473053 |
| clinical laboratories | 0.528717 |
| EV | 0.768749 |
| non-enveloped RNA viruses | 0.474125 |
| EV activity | 0.496004 |
| CVA6 detections | 0.544358 |
| Type-based enterovirus surveillance | 0.483136 |
| HPeV | 0.620292 |
| laboratories | 0.591346 |
| public health laboratories | 0.521519 |
| passive surveillance | 0.469412 |
|
| commonly reported specimen | 0.541604 |
| United States | 0.956007 |
| severe clinical outcomes | 0.477284 |
| Glen R. Abedi | 0.469267 |
| common EV type | 0.582429 |
| predominant circulating type | 0.494653 |
| specimen types | 0.464753 |
| type) data. | 0.507515 |
| virus type | 0.634502 |
| HPeV types | 0.565213 |
| public health | 0.691216 |
| types | 0.622708 |
| specimen collection date | 0.468419 |
| John T. Watson | 0.474436 |
| EV circulation | 0.502133 |
| EV molecular methods | 0.55225 |
| Enteric Virus Surveillance | 0.476958 |
| W. Allan Nix | 0.473251 |
| multiple U.S. states | 0.467256 |
| NESS | 0.695009 |
| EV types | 0.60253 |
| specimen type | 0.479802 |
| EV species | 0.53687 |
| HPeV detections | 0.478739 |
|
CLICK HERE |
| 14071 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidelines for Pregnant Women During a Zika Virus Outbreak - United States, 2016 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| recent travel | 0.333206 |
| Zika virus | 0.925008 |
| Zika virus bite | 0.416821 |
| subsequent fetal abnormality | 0.335842 |
| pregnant women | 0.543228 |
| pregnant woman | 0.343225 |
| Zoonotic Infectious Diseases | 0.344678 |
| health care providers | 0.466789 |
| positive RT-PCR result | 0.332206 |
| National Center | 0.335416 |
| fetal brain abnormality | 0.334011 |
| Mathis A. Dengue | 0.33612 |
| Zika virus RNA | 0.430425 |
| laboratory evidence | 0.34341 |
| pregnancy | 0.333466 |
| ongoing Zika virus | 0.470159 |
| Zika virus disease | 0.511625 |
| fetal losses | 0.333221 |
| insect repellents | 0.338668 |
| Zika virus outbreak | 0.445874 |
| Zika virus transmission | 0.586729 |
| asymptomatic pregnant women | 0.35057 |
| maculopapular rash | 0.349424 |
| pregnancy management | 0.332046 |
| dengue virus IgM | 0.406379 |
|
| maternal Zika virus | 0.402614 |
| intrauterine infection | 0.343648 |
| fetal Zika virus | 0.421071 |
| intracranial calcifications | 0.332676 |
| concurrent infection | 0.33278 |
| Zika virus infection | 0.750232 |
| Zika virus immunoglobulin | 0.403419 |
| specific antiviral treatment | 0.357232 |
| amniotic fluid | 0.344223 |
| local health department | 0.384648 |
| maternal-fetal medicine | 0.332734 |
| acute onset | 0.347949 |
| local health departments | 0.332234 |
| Zika virus infections | 0.443775 |
| congenital infection | 0.332506 |
| chikungunya virus infection | 0.448261 |
| infectious disease specialist | 0.357293 |
| pregnant returning travelers | 0.347764 |
| antibody titers | 0.336072 |
| Zika virus RT-PCR | 0.417438 |
| Zika virus IgM | 0.405525 |
| et al | 0.338481 |
| Ultrasound Obstet Gynecol | 0.348583 |
| confirmatory neutralizing antibody | 0.335376 |
|
CLICK HERE |